ticker,nameOfIssuer,cusip,value,shares,allocation_percent,filingDate,reportDate,accessionNumber
CELG,Celgene Corp.,151020104,432250000.0,3609298,12.176169524956148,2016-02-09,2015-12-31,0000950123-16-013781
INCY,Incyte Corp.,45337C102,406732000.0,3750406,11.457345941525654,2016-02-09,2015-12-31,0000950123-16-013781
IONS,Ionis Pharmaceuticals Inc.,462222100,404393000.0,6529838,11.391458005102582,2016-02-09,2015-12-31,0000950123-16-013781
GILD,Gilead Sciences Inc.,375558103,280761000.0,2774596,7.908834082119637,2016-02-09,2015-12-31,0000950123-16-013781
RDUSEUR,Radius Health Inc.,750469207,262907000.0,4272140,7.405899829491373,2016-02-09,2015-12-31,0000950123-16-013781
ALXN,Alexion Pharmaceuticals Inc.,015351109,197317000.0,1034428,5.55827702060329,2016-02-09,2015-12-31,0000950123-16-013781
NBIX,Neurocrine Biosciences Inc.,64125C109,176586000.0,3121552,4.974299761096371,2016-02-09,2015-12-31,0000950123-16-013781
VRTX,Vertex Pharmaceuticals Inc.,92532F100,171814000.0,1365445,4.839875976311892,2016-02-09,2015-12-31,0000950123-16-013781
AGIO,Agios Pharmaceuticals Inc.,00847X104,140222000.0,2159921,3.9499522108233682,2016-02-09,2015-12-31,0000950123-16-013781
N/A,Medivation Inc.,58501N101,124771000.0,2581112,3.514708728278319,2016-02-09,2015-12-31,0000950123-16-013781
HALO,Halozyme Therapeutics Inc.,40637H109,121827000.0,7029832,3.4317783799117008,2016-02-09,2015-12-31,0000950123-16-013781
REGN,Regeneron Pharmaceuticals Inc.,75886F107,111288000.0,205000,3.1349023807826946,2016-02-09,2015-12-31,0000950123-16-013781
ALNY,Alnylam Pharmaceuticals Inc.,02043Q107,106613000.0,1132499,3.003211015764372,2016-02-09,2015-12-31,0000950123-16-013781
N/A,Novavax Inc.,670002104,69889000.0,8330000,1.9687225261530599,2016-02-09,2015-12-31,0000950123-16-013781
T8S,Tesaro Inc.,881569107,64332000.0,1229582,1.8121858597558795,2016-02-09,2015-12-31,0000950123-16-013781
N/A,Cempra Inc.,15130J109,62008000.0,1991900,1.7467204624719048,2016-02-09,2015-12-31,0000950123-16-013781
N/A,"Juno Therapeutics, Inc.",48205A109,57381000.0,1305000,1.6163812226986898,2016-02-09,2015-12-31,0000950123-16-013781
ALDR1EUR,Alder Biopharmaceuticals Inc.,014339105,49880000.0,1510150,1.4050834838746389,2016-02-09,2015-12-31,0000950123-16-013781
N/A,"Kite Pharma, Inc.",49803L109,46215000.0,750000,1.3018430875554619,2016-02-09,2015-12-31,0000950123-16-013781
PTCT,PTC Therapeutics Inc.,69366J200,42214000.0,1302912,1.1891378145205294,2016-02-09,2015-12-31,0000950123-16-013781
SAGE,"Sage Therapeutics, Inc.",78667J108,41315000.0,708663,1.1638136354506956,2016-02-09,2015-12-31,0000950123-16-013781
ICPTUSD,Intercept Pharmaceuticals Inc.,45845P108,38192000.0,255719,1.075840986690862,2016-02-09,2015-12-31,0000950123-16-013781
PBYI,Puma Biotechnology Inc.,74587V107,33868000.0,431991,0.954037037527391,2016-02-09,2015-12-31,0000950123-16-013781
PRTA,Prothena Corp. PLC,G72800108,21795000.0,320000,0.6139493691068114,2016-02-09,2015-12-31,0000950123-16-013781
INFIQ,Infinity Pharmaceuticals Inc.,45665G303,21201000.0,2700737,0.597216819198601,2016-02-09,2015-12-31,0000950123-16-013781
ESPR,"Esperion Therapeutics, Inc.",29664W105,20224000.0,908542,0.5696954366054671,2016-02-09,2015-12-31,0000950123-16-013781
CLVSEUR,Clovis Oncology Inc.,189464100,18487000.0,528188,0.5207654042981245,2016-02-09,2015-12-31,0000950123-16-013781
ACHNEUR,Achillion Pharmaceuticals Inc.,00448Q201,13804000.0,1279340,0.38884868507228376,2016-02-09,2015-12-31,0000950123-16-013781
N/A,"Cidara Therapeutics, Inc.",171757107,8008000.0,466679,0.22557956172550336,2016-02-09,2015-12-31,0000950123-16-013781
TTPHEUR,Tetraphase Pharmaceuticals Inc.,88165N105,3673000.0,366203,0.10346575052669503,2016-02-09,2015-12-31,0000950123-16-013781
